Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 13Terminated 10Recruiting 5Unknown 4Active not recruiting 4Withdrawn 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

COVID-19 2Peripheral Nervous System Diseases 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × Hydroxychloroquine × Clear all
NCT04379492 2025-05-16

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn

COVID-19

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

University of Arizona

Phase 2 Withdrawn
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡